Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LINCOLN.NSthis companyLincoln Pharmaceuticals Limited	₹520.85	12.87×	1.49×	1.69×	8.5×	161.8%	32.8%	12.4%	13.1%	11.6%	8.1%	7.2%	0.01×	-0.13×	82.12×	5.25×	0.3%	4	—	3	B+
ININDSWFTLAB.BOInd-Swift Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
INDSWFTLAB.NSInd-Swift Laboratories Limited	₹349.05	26.55×	0.79×	1.71×	15.31×	-42.2%	29.7%	2.3%	6.5%	3.0%	0.9%	-9.8%	0.01×	-9.08×	10.31×	3.8×	0.0%	2	7.26	3	B
MAXIND.NSMax India Limited	₹151.30	-5.15×	1.54×	3.29×	-7.88×	-252.9%	-6.9%	-68.7%	-63.9%	-29.8%	-25.3%	-21.7%	0.24×	-0.23×	-9.5×	2.35×	0.0%	1	—	1	C-
SAKAR.NSSakar Healthcare Limited	₹1,028.65	36.38×	3.42×	4.41×	16.36×	-280.7%	26.3%	18.0%	12.1%	9.4%	8.8%	1.0%	0.17×	0.77×	5.77×	1.28×	0.0%	6	8.41	3	B
THTHEMISMED.BOThemis Medicare Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	26.55×	1.54×	3.29×	15.31×	-252.9%	26.3%	2.3%	6.5%	3.0%	0.9%	-9.8%	0.17×	-0.23×	5.77×	2.35×	0.0%	2	7.83	3	—